Nutraceutical EOU Sami-Sabinsa to invest ₹300 crore in two manufacturing facilities
Article featured in The Hindu BusinessLine, 14 July 2022
In a recent one-on-one discussion with The Hindu BusinessLine, Dr. Muhammed Majeed, Chairman and Founder, Sami-Sabinsa Group spoke about the company’s plans and the vision for the future. With the company clocking over ₹1,200 Crore in the Financial Year 2022, Dr. Majeed is certain that the nutritional fine chemical category would witness substantial growth in the years to come as we are adding new capacity at Hassan in Karnataka.
With 95% of Sami-Sabinsa business coming from exports, Dr. Majeed is also optimistic about the Indian market's potential. What’s more, the launch of Initial Public Offering (IPO) is also underway in the next two years for the company.
